Session

Coeliac disease (Posters)

STRATEGIES FOR IMPROVING INTER-READER VARIABILITY OF VILLUS HEIGHT AND CRYPT DEPTH MEASUREMENTS ACROSS DIFFERENT INSTITUTIONS​​​​
STRATEGIES FOR IMPROVING INTER-READER VARIABILITY OF VILLUS HEIGHT AND CRYPT DEPTH MEASUREMENTS ACROSS DIFFERENT INSTITUTIONS​​​​

Coeliac disease (Posters)  et al.

INCREASED RISK OF GASTROINTESTINAL CANCERS IN COELIAC DISEASE: A NATIONWIDE COHORT STUDY
INCREASED RISK OF GASTROINTESTINAL CANCERS IN COELIAC DISEASE: A NATIONWIDE COHORT STUDY

Coeliac disease (Posters)  et al.

FIRST IN HUMAN TRIAL OF IMU-856, AN ORALLY AVAILABLE EPIGENETIC MODULATOR OF BARRIER REGENERATION FOR THE TREATMENT OF CELIAC DISEASE
FIRST IN HUMAN TRIAL OF IMU-856, AN ORALLY AVAILABLE EPIGENETIC MODULATOR OF BARRIER REGENERATION FOR THE TREATMENT OF CELIAC DISEASE

Coeliac disease (Posters)  et al.

DIAGNOSTIC ACCURACY OF THE NO-BIOPSY APPROACH FOR THE DIAGNOSIS OF COELIAC DISEASE IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
DIAGNOSTIC ACCURACY OF THE NO-BIOPSY APPROACH FOR THE DIAGNOSIS OF COELIAC DISEASE IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Coeliac disease (Posters)  et al.

GUT-DRIVEN VASCULAR INFLAMMATION AND OXIDATIVE STRESS: EXPLORING THE MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN AN EXPERIMENTAL COELIAC DISEASE MODEL
GUT-DRIVEN VASCULAR INFLAMMATION AND OXIDATIVE STRESS: EXPLORING THE MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN AN EXPERIMENTAL COELIAC DISEASE MODEL

Coeliac disease (Posters)  et al.

EPITHELIAL BARRIER FUNCTION SECONDARY TO MICROORGANISMS-INDUCED POLARITY DEFECTS – MECHANISM IN CELIAC DISEASE INITIATION?
EPITHELIAL BARRIER FUNCTION SECONDARY TO MICROORGANISMS-INDUCED POLARITY DEFECTS – MECHANISM IN CELIAC DISEASE INITIATION?

Coeliac disease (Posters)  et al.

GLUTEN-FREE DIET INVOKES INSTANT CHANGES IN PHENOTYPE AND SURVIVAL PROPERTIES OF GLUTEN-SPECIFIC T CELLS IN CELIAC DISEASE
GLUTEN-FREE DIET INVOKES INSTANT CHANGES IN PHENOTYPE AND SURVIVAL PROPERTIES OF GLUTEN-SPECIFIC T CELLS IN CELIAC DISEASE

Coeliac disease (Posters)  et al.

LOW-DOSE GLUTEN CHALLANGE BY USING “CRACKERS” IN SUBJECTS WITH DOUBT CELIAC DISEASE OF ADULTS
LOW-DOSE GLUTEN CHALLANGE BY USING “CRACKERS” IN SUBJECTS WITH DOUBT CELIAC DISEASE OF ADULTS

Coeliac disease (Posters)  et al.

EPIGENOME-WIDE ASSOCIATION STUDY IN PAEDIATRIC COELIAC DISEASE IDENTIFIES SIGNIFICANT METHYLATION ALTERATIONS IN WHOLE BLOOD
EPIGENOME-WIDE ASSOCIATION STUDY IN PAEDIATRIC COELIAC DISEASE IDENTIFIES SIGNIFICANT METHYLATION ALTERATIONS IN WHOLE BLOOD

Coeliac disease (Posters)  et al.

STRATEGIES FOR IMPROVING INTER-READER VARIABILITY OF VILLUS HEIGHT AND CRYPT DEPTH MEASUREMENTS ACROSS DIFFERENT INSTITUTIONS​​​​
STRATEGIES FOR IMPROVING INTER-READER VARIABILITY OF VILLUS HEIGHT AND CRYPT DEPTH MEASUREMENTS ACROSS DIFFERENT INSTITUTIONS​​​​

INCREASED RISK OF GASTROINTESTINAL CANCERS IN COELIAC DISEASE: A NATIONWIDE COHORT STUDY
INCREASED RISK OF GASTROINTESTINAL CANCERS IN COELIAC DISEASE: A NATIONWIDE COHORT STUDY

GUT-DRIVEN VASCULAR INFLAMMATION AND OXIDATIVE STRESS: EXPLORING THE MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN AN EXPERIMENTAL COELIAC DISEASE MODEL
GUT-DRIVEN VASCULAR INFLAMMATION AND OXIDATIVE STRESS: EXPLORING THE MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN AN EXPERIMENTAL COELIAC DISEASE MODEL

EPITHELIAL BARRIER FUNCTION SECONDARY TO MICROORGANISMS-INDUCED POLARITY DEFECTS – MECHANISM IN CELIAC DISEASE INITIATION?
EPITHELIAL BARRIER FUNCTION SECONDARY TO MICROORGANISMS-INDUCED POLARITY DEFECTS – MECHANISM IN CELIAC DISEASE INITIATION?

GLUTEN-FREE DIET INVOKES INSTANT CHANGES IN PHENOTYPE AND SURVIVAL PROPERTIES OF GLUTEN-SPECIFIC T CELLS IN CELIAC DISEASE
GLUTEN-FREE DIET INVOKES INSTANT CHANGES IN PHENOTYPE AND SURVIVAL PROPERTIES OF GLUTEN-SPECIFIC T CELLS IN CELIAC DISEASE

EPIGENOME-WIDE ASSOCIATION STUDY IN PAEDIATRIC COELIAC DISEASE IDENTIFIES SIGNIFICANT METHYLATION ALTERATIONS IN WHOLE BLOOD
EPIGENOME-WIDE ASSOCIATION STUDY IN PAEDIATRIC COELIAC DISEASE IDENTIFIES SIGNIFICANT METHYLATION ALTERATIONS IN WHOLE BLOOD

FIRST IN HUMAN TRIAL OF IMU-856, AN ORALLY AVAILABLE EPIGENETIC MODULATOR OF BARRIER REGENERATION FOR THE TREATMENT OF CELIAC DISEASE
FIRST IN HUMAN TRIAL OF IMU-856, AN ORALLY AVAILABLE EPIGENETIC MODULATOR OF BARRIER REGENERATION FOR THE TREATMENT OF CELIAC DISEASE

DIAGNOSTIC ACCURACY OF THE NO-BIOPSY APPROACH FOR THE DIAGNOSIS OF COELIAC DISEASE IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
DIAGNOSTIC ACCURACY OF THE NO-BIOPSY APPROACH FOR THE DIAGNOSIS OF COELIAC DISEASE IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

LOW-DOSE GLUTEN CHALLANGE BY USING “CRACKERS” IN SUBJECTS WITH DOUBT CELIAC DISEASE OF ADULTS
LOW-DOSE GLUTEN CHALLANGE BY USING “CRACKERS” IN SUBJECTS WITH DOUBT CELIAC DISEASE OF ADULTS

Item 1 - 18 / 18
1